Bispecific monoclonal antibodies mediate binding of dengue virus to erythrocytes in a monkey model of passive viremia.
about
Screening of Methanolic Plant Extracts against Larvae of Aedes aegypti and Anopheles stephensi in MysoreDelivery of drugs bound to erythrocytes: new avenues for an old intravascular carrierRhesus macaque antibody molecules: sequences and heterogeneity of alpha and gamma constant regionsUtility, limitations, and future of non-human primates for dengue research and vaccine developmentAnti-CD3/anti-epidermal growth factor receptor-bispecific antibody retargeting of lymphocytes against human neoplastic keratinocytes in an autologous organotypic culture model.Drug delivery by red blood cells: vascular carriers designed by mother nature.The basic rules and methods of mosquito rearing (Aedes aegypti).Red blood cells: Supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems.Erythrocytes as Carriers for Drug Delivery in Blood Transfusion and Beyond.Bispecific antibodies for viral immunotherapy.Effect of confertifolin from Polygonum hydropiper L. against dengue vector mosquitoes Aedes aegypti L.Larvicidal efficacy of Adhatoda vasica (L.) Nees against the bancroftian filariasis vector Culex quinquefasciatus Say and dengue vector Aedes aegypti L. in in vitro condition.Evaluation of larvicidal activity of Acalypha alnifolia Klein ex Willd. (Euphorbiaceae) leaf extract against the malarial vector, Anopheles stephensi, dengue vector, Aedes aegypti and Bancroftian filariasis vector, Culex quinquefasciatus (Diptera: CBiochemical evidence of efficacy of potash alum for the control of dengue vector Aedes aegypti (Linnaeus).Isolation and identification of mosquito larvicidal compound from Abutilon indicum (Linn.) Sweet.Improvement of the Dengue Virus (DENV) Nonhuman Primate Model via a Reverse Translational Approach Based on Dengue Vaccine Clinical Efficacy Data against DENV-2 and -4.
P2860
Q26315324-57EC700B-E26A-4D91-B9A1-A279BF19DF83Q26801300-7733E5FC-FAF8-4AFD-A6EC-F9C2F851C031Q27478005-B270442B-4644-4B23-83E0-D9A0402B0BD7Q34238916-4F96625D-5441-4FA7-B410-D4A83222D61EQ35750258-2A47AD82-957E-44A5-BE06-4E3E057C5781Q37700751-0FEBC74B-4350-4B6B-8876-49D21D091B70Q37712193-8BC57871-80C6-44B0-AE1B-33AAAC99EBD3Q38760096-8825B8FC-0C2C-4928-B9B2-58A0FFC1A97BQ38972974-D3748E7B-9EB7-4EB0-93DF-0C39DBFC274AQ38992408-6CBD85EC-37E3-4747-9F93-ED2E898BF5CFQ40177171-E6F2AA2C-71BD-4011-BE8C-7EEF96264923Q40302898-FF6E16C1-809E-4E14-A9CE-280C97F59D7FQ40318763-158D767C-40BA-4F04-BD0F-05FE6FBBF722Q40339692-4E9B5CFB-F385-4C74-B28B-66AFBACBE60DQ43047833-18B8F1F4-FE26-4200-918F-199FEC0F7DF1Q51733262-CFEB4385-B55F-4586-ADB3-6A40F977268C
P2860
Bispecific monoclonal antibodies mediate binding of dengue virus to erythrocytes in a monkey model of passive viremia.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Bispecific monoclonal antibodi ...... nkey model of passive viremia.
@ast
Bispecific monoclonal antibodi ...... nkey model of passive viremia.
@en
type
label
Bispecific monoclonal antibodi ...... nkey model of passive viremia.
@ast
Bispecific monoclonal antibodi ...... nkey model of passive viremia.
@en
prefLabel
Bispecific monoclonal antibodi ...... nkey model of passive viremia.
@ast
Bispecific monoclonal antibodi ...... nkey model of passive viremia.
@en
P2093
P1476
Bispecific monoclonal antibodi ...... nkey model of passive viremia.
@en
P2093
P304
P356
10.4049/JIMMUNOL.166.2.1057
P407
P577
2001-01-01T00:00:00Z